Journal of Viral Hepatitis


24 Nov 2021
Researchers from the Osaka City University Graduate School of Medicine have shown in patients with early-stage hepatocellular carcinoma who received cancer treatment that eliminating the hepatitis C virus with a direct-acting antiviral treatment reduces the risk of the liver cancer progression and increases overall patient survival.


Sorry, no events coming up for this topic.


Sorry, no researchers coming up for this topic.